Work

Clinical Outcomes of an Amorphous Hydrated Silica-Containing Topical Cream in Three Adults With Atopic Dermatitis: A Case Series

Year: 2026
Type: article
Study design: Case Report
Abstract: Atopic dermatitis is characterized by recurrent eczematous inflammation, pruritus, and xerosis, and topical moisturizers remain an important component of management. We describe a retrospective case series of three adults, aged 28-42 years, treated in an outpatient dermatology practice with an amorphous hydrated silica-containing prescription topical cream. Baseline and approximately Day 14 assessments included Investigator Global Assessment (IGA), pruritus numerical rating scale (NRS), and Overall Dry Skin Score (ODS). The planned regimen was twice-daily application for four weeks, although the actual treatment duration varied according to the clinical course. On Day 14, all three patients had IGA scores of 0 or 1, with reductions of at least 2 IGA points, 6 pruritus NRS points, and 1 ODS point from baseline. Pruritus NRS decreased by 6, 7, and 7 points in Patients 1, 2, and 3, respectively. Patients 1 and 2 continued use through Week 4 for comfort, whereas Patient 3 discontinued treatment after five days following reported resolution. No concomitant therapies or recent topical corticosteroid use were reported during the treatment period. Transient burning occurred with the initial application in one patient and did not recur; no adverse events were reported in the other two patients. These observations are limited by the retrospective design, small sample size, absence of a control group, variable treatment exposure, and short follow-up. The concordant reductions in clinician-assessed disease severity, patient-reported pruritus, and xerosis support further prospective evaluation of this silica-containing topical emulsion in atopic dermatitis.
Source: Cureus
Language: English
Subfield: Dermatology
Field: Medicine
Open Access status: diamond
OpenAlex ID: W7236830684
FWCI:
Cites: 4
Cited by:
Related to: 10